ABOUT US
TECHNOLOGY
- EXACT Technology
- Manufacturing
PIPELINE
- Partnerships
- Clinical Trials
PATIENTS AND FAMILIES
INVESTORS
CAREERS
CONTACT US
TWITTER
LINKEDIN
FACEBOOK

Focusing on the Future of Life-Changing Genetic Medicines

Gene therapy holds incredible promise to revolutionize medical treatment. At Neurogene we believe that innovation, robust scientific execution, and a strong sense of purpose are required to turn this promise into reality. Our focus is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.

Learn More >>

OUR PIPELINE

We are building a gene therapy pipeline to help address the high unmet need for rare neurological diseases.

LEARN MORE

ABOUT US

At Neurogene, we are driven by a strong sense of purpose to advance genetic medicines.

LEARN MORE

LATEST NEWS

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK --(BUSINESS WIRE)--Jul. 3, 2025-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to…

Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome

Written agreement from FDA for single-arm, open-label, baseline-controlled registrational trial evaluating composite primary endpoint of improvement in CGI-I and gain…

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK --(BUSINESS WIRE)--Jun. 6, 2025-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to…